PMC:7311890 / 37160-37431
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T46 | 138-141 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T47 | 138-141 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T48 | 170-173 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T49 | 170-173 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
T50 | 231-234 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
T51 | 231-234 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T328 | 239-243 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 1/16 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T630 | 138-141 | Chemical | denotes | GM3 | http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118 |
T632 | 142-147 | Chemical | denotes | d18:0 | http://purl.obolibrary.org/obo/CHEBI_16566 |
T633 | 170-173 | Chemical | denotes | GM3 | http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118 |
T635 | 180-184 | Chemical | denotes | 24:1 | http://purl.obolibrary.org/obo/CHEBI_36032 |
T636 | 231-234 | Chemical | denotes | GM3 | http://purl.obolibrary.org/obo/CHEBI_15681|http://purl.obolibrary.org/obo/CHEBI_84118 |
T638 | 267-269 | Chemical | denotes | 5B | http://purl.obolibrary.org/obo/CHEBI_27560 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
1127 | 80-84 | Chemical | denotes | GM3s |
1128 | 138-141 | Chemical | denotes | GM3 |
1129 | 170-173 | Chemical | denotes | GM3 |
1130 | 231-234 | Chemical | denotes | GM3 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T233 | 0-271 | Sentence | denotes | Progressive increases with increasing disease severity were similarly noted for GM3s of varying acyl chain lengths, e.g., very long-chain GM3 d18:0/26:0 (p = 0.0008) and GM3 d18:1/24:1 (p = 0.0015), as well as medium-chain such as GM3 d18:1/16:0 (p = 0.0017) (Figure 5B). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T821 | 80-84 | PR:000015682 | denotes | GM3s |
T822 | 96-100 | CHEBI:22221;CHEBI:22221 | denotes | acyl |
T823 | 101-114 | CHEBI:61910;CHEBI:61910 | denotes | chain lengths |
T824 | 122-132 | CHEBI:61910;CHEBI:61910 | denotes | very long- |
T598 | 10-15 | CHEBI:18059;CHEBI:18059 | denotes | e inc |
T599 | 30-44 | CHEBI:74537;CHEBI:74537 | denotes | reasing diseas |
T600 | 45-54 | CHEBI:18367;CHEBI:18367 | denotes | severity |
T601 | 106-118 | CHEBI:64583;CHEBI:64583 | denotes | lengths, e. |